These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17616537)

  • 1. End-stage disease of native kidneys in a patient with biopsy-proven Arndt-Gottron scleromyxoedema and recurrence in the transplanted kidney.
    Peeters P; Praet M; Van Vlem B; Naeyaert JM; Vanholder R
    Nephrol Dial Transplant; 2007 Oct; 22(10):3065-9. PubMed ID: 17616537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic active thrombotic microangiopathy in native and transplanted kidneys.
    Zhang PL; Prichard JW; Lin F; Shultz MF; Malek SK; Shaw JH; Hartle JE
    Ann Clin Lab Sci; 2006; 36(3):319-25. PubMed ID: 16951274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Arndt-Gottron scleromyxedema. Case report and review of therapeutic possibilities].
    Schirren CG; Betke M; Eckert F; Przybilla B
    Hautarzt; 1992 Mar; 43(3):152-7. PubMed ID: 1577603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful therapy of scleromyxoedema Arndt-Gottron with low-dose intravenous immunoglobulin.
    Körber A; Franckson T; Grabbe S; Dissemond J
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):553-4. PubMed ID: 17373996
    [No Abstract]   [Full Text] [Related]  

  • 5. CKD stage-to-stage progression in native and transplant kidney disease.
    Kukla A; Adulla M; Pascual J; Samaniego M; Nanovic L; Becker BN; Djamali A
    Nephrol Dial Transplant; 2008 Feb; 23(2):693-700. PubMed ID: 17881429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic kidney disease management: comparison between renal transplant recipients and nontransplant patients with chronic kidney disease.
    Akbari A; Hussain N; Karpinski J; Knoll GA
    Nephron Clin Pract; 2007; 107(1):c7-13. PubMed ID: 17622770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney].
    Tomilina NA; Storozhakov GI; Gendlin GE; Badaeva SV; Zhidkova DA; Kim IG; Borisovskaia SV; Loss KE; Fedorova ND
    Ter Arkh; 2007; 79(6):34-40. PubMed ID: 17684964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiopoietin 2 and cardiovascular disease in dialysis and kidney transplantation.
    David S; Kümpers P; Hellpap J; Horn R; Leitolf H; Haller H; Kielstein JT
    Am J Kidney Dis; 2009 May; 53(5):770-8. PubMed ID: 19268412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Arndt-Gottron scleromyxedema. Summary of 2 years treatment].
    Krajnc I
    Wien Klin Wochenschr; 1997 Dec; 109(24):960-3. PubMed ID: 9491540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical improvement of nephrogenic systemic fibrosis after kidney transplantation.
    Panesar M; Banerjee S; Barone GW
    Clin Transplant; 2008; 22(6):803-8. PubMed ID: 18713261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of kidney function and biopsy results in liver failure patients with renal dysfunction: a new look to combined liver kidney allocation in the post-MELD era.
    Tanriover B; Mejia A; Weinstein J; Foster SV; Ghalib R; Mubarak A; Cheng SS
    Transplantation; 2008 Dec; 86(11):1548-53. PubMed ID: 19077888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous renal transplantation and native nephrectomy in patients with autosomal-dominant polycystic kidney disease.
    Nunes P; Mota A; Alves R; Figueiredo A; Parada B; Macário F; Rolo F
    Transplant Proc; 2007 Oct; 39(8):2483-5. PubMed ID: 17954154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Can the renal transplant patient be really considered as a patient with chronic renal insufficiency?].
    Djamali A
    Nephrol Ther; 2008 Jun; 4 Suppl 1():S36-S39. PubMed ID: 18703397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Internal disease findings in Arndt-Gottron scleromyxedema].
    Lang E; Goos M
    Dtsch Med Wochenschr; 1986 May; 111(21):820-3. PubMed ID: 3084193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation.
    Tang Z; Ji SM; Chen DR; Wen JQ; Chen JS; Liu ZH; Li LS
    Ren Fail; 2008; 30(6):611-6. PubMed ID: 18661411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arndt-Gottron scleromyxoedema: successful therapy with intravenous immunoglobulins.
    Gholam P; Hartmann M; Enk A
    Br J Dermatol; 2007 Nov; 157(5):1058-60. PubMed ID: 17854360
    [No Abstract]   [Full Text] [Related]  

  • 17. Scleromyxoedema: a cause for unexplained encephalopathy and myositis.
    Tan E; Lau N; Yung A
    Clin Exp Dermatol; 2010 Oct; 35(7):746-8. PubMed ID: 20345991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical characteristics, outcome of scleromyxoedema: a retrospective multicentre study].
    Le Moigne M; Mazereeuw-Hautier J; Bonnetblanc JM; Astudillo L; D'Incan M; Bessis D; Thomas L; Debarbieux S; Ammoury A; Lamant L; Paul C
    Ann Dermatol Venereol; 2010 Dec; 137(12):782-8. PubMed ID: 21134580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalidomide and dexamethasone followed by autologous stem cell transplantation for scleromyxoedema.
    Bos R; de Waal EG; Kuiper H; Hazenberg BP; Vellenga E
    Rheumatology (Oxford); 2011 Oct; 50(10):1925-6. PubMed ID: 21719421
    [No Abstract]   [Full Text] [Related]  

  • 20. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
    Wong CF; McCarthy M; Howse ML; Williams PS
    Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.